Skip to content

Comparing Concussion Education Types

Comparison of Concussion Education Types

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05836662
Enrollment
40
Registered
2023-05-01
Start date
2023-04-19
Completion date
2024-07-31
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Concussion, Knowledge, Attitudes, Practice

Brief summary

The purpose of this study is to determine if there are differences in knowledge, self-efficacy, and empathy surrounding concussions, as well as intent to report a concussion, after viewing concussion education (CrashCourse and Brain Fly-Through) in 2D versus in 3D. In this randomized study, all participants will receive two types of concussion education (CrashCourse and Brain Fly-Through). Participants will be randomized to the 2D or 3D (Virtual Reality) group, and will experience both concussion educations in that modality (either 2D or 3D).

Detailed description

In this randomized study, all participants will receive two types of concussion education (CrashCourse and Brain Fly-Through). Participants will be randomized to the 2D or 3D (Virtual Reality) group, and will experience both concussion educations in that modality (either 2D or 3D). During their in person study visit, participants will complete a brief ( \ 5 minute) pre-survey before viewing the CrashCourse and Brain Fly-Through concussion educations. Participants will then be asked to complete a brief ( \ 2 minute) survey to assess their knowledge, self-efficacy, and empathy surrounding concussions. Two months later, participants will receive a brief ( \ 5 minute) follow-up survey via email, assessing the same constructs.

Interventions

OTHERCrashCourse Concussion Education in Virtual Reality

The TeachAids concussion education, including CrashCourse and Brain Fly-Through, will be shown in 3D (via a Virtual Reality headset). These educations are the exact same content as the 2D versions viewed on a laptop, but the modality (via a VR headset) is different.

Sponsors

Massachusetts General Hospital
CollaboratorOTHER
Concordia University Wisconsin
CollaboratorOTHER
Piya Sorcar
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

In this randomized study, all participants will receive two types of concussion education (CrashCourse and Brain Fly-Through). Participants will be randomized to the 2D or 3D (Virtual Reality) group, and will experience both concussion educations in that modality (either 2D or 3D). During their in person study visit, participants will complete a brief ( \ 5 minute) pre-survey before viewing the CrashCourse and Brain Fly-Through concussion educations. Participants will then be asked to complete a brief ( \ 2 minute) survey to assess their knowledge, self-efficacy, and empathy surrounding concussions. Two months later, participants will receive a brief ( \ 5 minute) follow-up survey via email, assessing the same constructs.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* at least 18 years of age * health professions student (ex: Nursing, PT, OT, Pharmacy, Athletic Training) and/or a student-athlete at Concordia University (Ann Arbor or Mequon campus)

Exclusion criteria

\- have previously viewed the TeachAids CrashCourse concussion education

Design outcomes

Primary

MeasureTime frameDescription
Change in the participant's knowledge, self-efficacy, and empathy surrounding concussions2 monthsParticipants will take a pre-survey (prior to receiving the concussion education), an immediate post-survey (right after completion of the concussion education), and two-month post-survey (two months after the concussion education. These surveys will assess participant's knowledge, self-efficacy, and empathy surrounding concussions.

Countries

United States

Contacts

Primary ContactDaniel H Daneshvar, MD, PhD
ddaneshvar@mgh.harvard.edu617-952-5299

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026